Rybelsus in Canada

What is sold here

Novo Nordisk announced the updated Rybelsus formulation (1.5 mg, 4 mg and 9 mg tablets) in Canada on 9 June 2026. The new tablets are absorbed better, so lower numbers give the same effect: 3 mg old = 1.5 mg new, 7 mg = 4 mg, 14 mg = 9 mg. They are not interchangeable milligram for milligram, so ask your prescriber or pharmacist before switching. In September 2026 all six strengths were still listed on the Ontario Drug Benefit Formulary (the new ones from 31 March 2026), so pharmacies may stock either during the changeover.

There is no generic oral semaglutide (generic Rybelsus) in Canada. Every generic semaglutide Health Canada has approved since April 2026 is an injection.

What it is licensed for

Type 2 diabetes in adults, alongside diet and exercise, to improve blood sugar control. In 2026 Health Canada also approved Rybelsus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack or non-fatal stroke) in adults with type 2 diabetes who have established cardiovascular disease or are at high risk of these events. It is not approved for weight management.

Prescription rules

Prescription drug. You need a prescription from a physician, nurse practitioner or other prescriber authorised in your province or territory, dispensed by a provincially licensed pharmacy.

How to get a prescription

Start with your family doctor or nurse practitioner, or a walk-in or virtual clinic in your province. If Rybelsus is suitable, they will prescribe it and you can fill the prescription at any licensed pharmacy, in person or by delivery. If you have provincial or private drug coverage, the pharmacy will bill your plan; in Ontario, Rybelsus is covered for eligible ODB recipients who meet the Limited Use criteria, while BC PharmaCare does not cover it.

Several virtual care services, such as Felix and Pocketpills, have their own clinicians and licensed pharmacies: you complete an online assessment, a prescriber reviews it (sometimes with a phone or video call), and the medicine is shipped to you. You can usually only use them if you live in a province where they operate.

Rybelsus is approved for type 2 diabetes, not for weight loss. For weight management, Health Canada has approved Wegovy, Zepbound and, since June 2026, the generic semaglutide injection Sevmia; ask your prescriber which option suits you. Cheaper generic semaglutide injections are now also available for type 2 diabetes, but there is still no generic tablet.

Cost and cover

Provincial drug plans (Ontario Drug Benefit, BC PharmaCare, RAMQ and others) and private insurance

Coverage depends on your province. Ontario: Rybelsus is a Limited Use benefit on the Ontario Drug Benefit (ODB) Formulary (reason for use code 738) for adults with type 2 diabetes whose blood sugar is not adequately controlled on the maximum tolerated dose of metformin, or when metformin is contraindicated or inappropriate. It is not funded together with another GLP-1 receptor agonist or a DPP-4 inhibitor, and Ontario pays for only one form of semaglutide (tablets or injection), not both. ODB recipients aged 65 and over pay the first $100 of prescription costs each program year (August to July), then up to $6.11 per prescription; lower-income seniors, social assistance recipients and long-term care residents pay up to $2; people under 25 without private insurance are covered through OHIP+ at no cost.

British Columbia: the PharmaCare formulary search (coverage information updated 8 September 2026) lists Rybelsus 3 mg, 7 mg and 14 mg as a Non-Benefit, so PharmaCare does not pay for it, and the new 1.5/4/9 mg strengths are not listed. BC PharmaCare does cover semaglutide injection (Ozempic and the generics) with Special Authority.

Quebec: the RAMQ covers Rybelsus as an exception drug (medicament d'exception), which is reimbursed only when RAMQ's clinical criteria are met. For the new 1.5/4/9 mg strengths, INESSS recommended conditional listing (published 4 June 2025) and the minister decided on 30 July 2026 to list them as exception drugs.

Other provinces and territories set their own rules; we have not checked them. Private (employer) drug plans decide coverage themselves, so check with your insurer whether prior authorisation is needed.

Paying yourself

Canadian drug prices are not set nationally and vary by province and pharmacy. Ontario's drug benefit price for Rybelsus is CAD 7.5303 per tablet for every strength, about CAD 225.91 for 30 tablets; this is what the Ontario plan pays for the drug itself, and people paying cash also pay the pharmacy's markup and dispensing fee. Felix, an online service with its own pharmacy, lists Rybelsus refills at CAD 322.80 (Ontario price after Novo Nordisk's patient support program discount, strength not stated, prices last updated 21 May 2026) and the first 30 days at CAD 0. Ask your pharmacy for a quote, and check whether your provincial or private plan covers it.

Prices checked 22 September 2026. They change; the supplier's own site is the final word.

Checking a pharmacy is genuine

Every pharmacy in Canada must be licensed by the regulator of the province or territory it operates in. Find the pharmacy's legal name, address and licence or accreditation number on its website, then look it up on that regulator's public register; NAPRA (the National Association of Pharmacy Regulatory Authorities) links to all of them. In Ontario, for example, the College of Pharmacists' Find a Pharmacy search shows the accreditation number, owner and whether the pharmacy is Entitled to operate.

The CIPA seal is not a licence. The Canadian International Pharmacy Association is a trade association of licensed mail-order pharmacies, many of which serve customers in the US. CIPA says its members also work with international pharmacies and fulfilment centres outside Canada that ship directly to patients, so medicine ordered from a CIPA site may not come from Canada. CIPA also warns that its seal is sometimes copied, so check membership on cipa.com and check the dispensing pharmacy on the provincial register.

• Medicines regulatorHealth Canada ↗
• Pharmacy regulatorProvincial and territorial pharmacy regulatory authorities (for example the Ontario College of Pharmacists, the College of Pharmacists of British Columbia and the Ordre des pharmaciens du Quebec) ↗
• Prescriber regulatorProvincial and territorial colleges of physicians and surgeons, and nursing regulators for nurse practitioners (listed by FMRAC) ↗

Fake semaglutide is widespread. Any site that offers Rybelsus without a prescription, or at a price far below everyone else, should be avoided. How to buy safely.

Other options in Canada

How the other semaglutide and GLP-1 medicines stand here. Tablets first; injections for comparison.

• Wegovy pill Tablet · semaglutide (oral) Unconfirmed

  Not approved in Canada as of 22 September 2026, and we could not confirm whether Novo Nordisk has filed for it here. Health Canada does not confirm individual filings; its Submissions Under Review list (updated 31 July 2026) shows a supplemental semaglutide submission from Novo Nordisk Canada accepted in January 2026 but does not name the product, so it may or may not be the Wegovy pill.

• Foundayo Tablet · orforglipron Under review

  Eli Lilly's orforglipron (sold as Foundayo in the US) was accepted for Health Canada review in January 2026 as a new active substance under an aligned review. It was still on the Submissions Under Review list updated 31 July 2026, and we found no Canadian approval announcement.

• Ozempic Injection · semaglutide (injection) Available

  Weekly semaglutide injection for type 2 diabetes. Since the generics arrived, Ontario treats Ozempic and generic semaglutide as interchangeable: the ODB price for an Ozempic pen is CAD 227.94 but the plan pays up to the generic price of CAD 78.141. BC PharmaCare covers it with Special Authority.

• Wegovy Injection · semaglutide (injection) Available

  Weekly semaglutide injection for chronic weight management, available on private prescription. BC PharmaCare lists it as a Non-Benefit. Felix lists Wegovy at CAD 394.65 per pen (Ontario price, 21 May 2026).

• Mounjaro Injection · tirzepatide Available

  Weekly tirzepatide injection for type 2 diabetes; the same medicine is sold as Zepbound for weight management in Canada. Felix lists Mounjaro and Zepbound from CAD 350.60 per pen (2.5 mg) to CAD 501.88 (12.5 and 15 mg), Ontario prices as of 21 May 2026.

• Semaglutide Injection (Dr. Reddy's), Apo-Semaglutide and Sevmia (Apotex) Injection · semaglutide Available

  Injections only. Health Canada approved Dr. Reddy's semaglutide injection (equivalent to Ozempic, for type 2 diabetes) on 28 April 2026, Apotex's for type 2 diabetes on 1 May 2026, and Apotex's Sevmia (equivalent to Wegovy, for weight management from age 12) on 29 June 2026, with more applications under review. The Ontario Drug Benefit lists the Dr. Reddy's and Apotex pens at CAD 78.141 each. No generic oral semaglutide (generic Rybelsus) has been approved.